These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6141550)

  • 1. [The adenylate cyclase system of human platelets].
    Ferry N; Adnot S; Insel PA; Hanoune J
    Nouv Rev Fr Hematol (1978); 1983; 25(6):343-53. PubMed ID: 6141550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine.
    Jakobs KH; Saur W; Schultz G
    J Cyclic Nucleotide Res; 1976; 2(6):381-92. PubMed ID: 14175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
    Alvarez R; Taylor A; Fazzari JJ; Jacobs JR
    Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of forskolin with dually regulated adenylate cyclase.
    Seamon KB; Wetzel B
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():91-9. PubMed ID: 6328948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties required of a functional Ni, the GTP regulatory complex that mediates the inhibitory actions of neurotransmitters on adenylate cyclase.
    Cooper DM; Yeung SM; Perez-Reyes E; Owens JR; Fossom LH; Gill DL
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():75-86. PubMed ID: 2988305
    [No Abstract]   [Full Text] [Related]  

  • 6. Human platelet aggregation and cAMP system--cAMP level, adenyl cyclase, phosphodiesterase.
    Wang TY; Hussey CV; Sasse EA; Fobian JE
    Ann Clin Lab Sci; 1978; 8(5):403-12. PubMed ID: 213009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of adenylate cyclase from purified platelet membranes by prostaglandin E1 and its inhibition by L-epinephrine: mechanistic effects.
    Steer ML; Braun S; Lester HA; Levitzki A
    J Cyclic Nucleotide Res; 1982; 8(5):309-22. PubMed ID: 7182416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human platelet alpha 2-adrenergic receptors: effect of Na+ on interaction with the adenylate cyclase system and on epinephrine-stimulated platelet secretion.
    Limbird LE; Connolly TM; Sweatt JD; Uderman HD
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():235-42. PubMed ID: 2988299
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of halothane on the cyclic 3',5'-adenosine monophosphate enzyme system in human platelets.
    Walter F; Vulliemoz Y; Verosky Y; Triner L
    Anesth Analg; 1980 Nov; 59(11):856-61. PubMed ID: 6252800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
    Barovsky K; Pedone C; Brooker G
    Mol Pharmacol; 1984 Mar; 25(2):256-60. PubMed ID: 6321948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that adenosine diphosphate can activate adenylate cyclase via conversion to adenosine in platelet-rich plasma containing magnesium.
    Glenn JR; Heptinstall S
    Thromb Haemost; 1998 Aug; 80(2):321-5. PubMed ID: 9716160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-ketoprostaglandin E1 activates adenylate cyclase in human platelet membranes through prostacyclin receptors.
    Oliva D; Nicosia S
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():601-4. PubMed ID: 6328939
    [No Abstract]   [Full Text] [Related]  

  • 13. Forskolin: a unique diterpene activator of cyclic AMP-generating systems.
    Seamon KB; Daly JW
    J Cyclic Nucleotide Res; 1981; 7(4):201-24. PubMed ID: 6278005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha adrenergic response of Down's syndrome platelets.
    Sheppard JR; Schumacher W; White JG; Jakobs KH; Schultz G
    J Pharmacol Exp Ther; 1983 Jun; 225(3):584-8. PubMed ID: 6306212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium inhibits adenylate cyclase of human platelets.
    Imandt L; Tijhuis D; Wessels H; Haanen C
    Thromb Haemost; 1981 Apr; 45(2):142-5. PubMed ID: 6266068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct evidence for the role of the coupling proteins in forskolin activation of adenylate cyclase.
    Green DA; Clark RB
    J Cyclic Nucleotide Res; 1982; 8(5):337-46. PubMed ID: 6892111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of rat platelet adenylate cyclase by an endogenous calcium-dependent protease-like activity.
    Adnot S; Poirier-Dupuis M; Franks DJ; Hamet P
    J Cyclic Nucleotide Res; 1982; 8(2):103-18. PubMed ID: 6757289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of thrombin on adenyl cyclase activity and a membrane protein from human platelets.
    Brodie GN; Baenziger NL; Chase LR; Majerus PW
    J Clin Invest; 1972 Jan; 51(1):81-8. PubMed ID: 4331802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased platelet adenylate cyclase activity ion diabetic patients with microangiography.
    Janka HU; Standl E; Mehnert H
    Horm Metab Res Suppl; 1981; 11():26-9. PubMed ID: 6172351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
    Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.